At a glance
- Originator Pharmacia Corporation
- Class Anti-inflammatories; Benzopyrans
- Mechanism of Action Leukotriene B4 receptor antagonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- No development reported Dermatitis; Psoriasis; Ulcerative colitis
Most Recent Events
- 16 Apr 2003 Pharmacia has been acquired by Pfizer
- 03 Nov 1998 No-Development-Reported for Ulcerative colitis in USA (PO)
- 22 Sep 1998 No-Development-Reported for Dermatitis in USA (PO)